Verisense news prior to the spin off from Shimmer Research.
Irish Clinical Research Team Selects Shimmer’s Verisense to Study Breast Cancer-related Fatigue
Shimmer Research today announced that a team of researchers from Letterkenny Institute of Technology (LYIT) and Letterkenny University Hospital (LUH) will be using Shimmer’s Verisense™ continuous monitoring platform to study fatigue accurately in individuals with breast cancer.
Shimmer and ClearSky announce partnership to improve analysis of wearable sensor data for CNS diseases
Shimmer Research and ClearSky Medical Diagnostics today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research. This partnership will employ Shimmer's Verisense™ wearable sensors platform, which has been designed specifically for use in clinical research, with ClearSky algorithms and machine learning to transform wearables data into actionable insights for central nervous system (CNS) diseases.